In line with these studies, our findings experimentally confirmed the upregulation and oncogenic functions of FBXO43 in HCC, which was also associated with advanced clinical progression and predicted poor prognosis in HCC patients. Here, FBXO43 is linked to hepatocellular carcinoma.